On August 24th, XPENG Group (09868.HK) disclosed on the Hong Kong Stock Exchange that its R&D expenditure for the first half of 2026 soared to RMB 5.82 billion, marking a substantial 39.0% increase from the RMB 4.19 billion recorded during the same period in 2025. This significant growth was primarily propelled by heightened investments in new model development and AI-related technological research, as the company strategically broadened its product lineup to underpin future expansion.